233 related articles for article (PubMed ID: 37853327)
1. Directional versus ring-mode deep brain stimulation for Parkinson's disease: protocol of a multi-centre double-blind randomised crossover trial.
Brinke TRT; Jergas H; Sisodia V; Barbe MT; Odekerken VJJ; Verbaan D; Dijk JM; Bot M; Beudel M; van den Munckhof P; Schuurman PR; de Bie RMA
BMC Neurol; 2023 Oct; 23(1):372. PubMed ID: 37853327
[TBL] [Abstract][Full Text] [Related]
2. A multicenter double-blind randomized crossover study comparing the impact of dorsal subthalamic nucleus deep brain stimulation versus standard care on apathy in Parkinson's disease: a study protocol.
Zoon TJC; van Rooijen G; Contarino MF; van der Gaag S; Zutt R; van Asseldonk JT; van den Munckhof P; Schuurman PR; Denys DAJP; de Bie RMA
Trials; 2024 Feb; 25(1):104. PubMed ID: 38308317
[TBL] [Abstract][Full Text] [Related]
3. Automated deep brain stimulation programming based on electrode location: a randomised, crossover trial using a data-driven algorithm.
Roediger J; Dembek TA; Achtzehn J; Busch JL; Krämer AP; Faust K; Schneider GH; Krause P; Horn A; Kühn AA
Lancet Digit Health; 2023 Feb; 5(2):e59-e70. PubMed ID: 36528541
[TBL] [Abstract][Full Text] [Related]
4. Protocol of a randomized controlled trial investigating Deep Brain Stimulation for MOtor symptoms in patients with Parkinson's disease DEmentia (DBS-MODE).
Sisodia V; Swinnen BEKS; Dijk JM; Verwijk E; van Rooijen G; Lemstra AW; Schuurman PR; de Bie RMA
BMC Neurol; 2023 Apr; 23(1):160. PubMed ID: 37085773
[TBL] [Abstract][Full Text] [Related]
5. Directional Deep Brain Stimulation for Parkinson's Disease: Results of an International Crossover Study With Randomized, Double-Blind Primary Endpoint.
Schnitzler A; Mir P; Brodsky MA; Verhagen L; Groppa S; Alvarez R; Evans A; Blazquez M; Nagel S; Pilitsis JG; Pötter-Nerger M; Tse W; Almeida L; Tomycz N; Jimenez-Shahed J; Libionka W; Carrillo F; Hartmann CJ; Groiss SJ; Glaser M; Defresne F; Karst E; Cheeran B; Vesper J;
Neuromodulation; 2022 Aug; 25(6):817-828. PubMed ID: 34047410
[TBL] [Abstract][Full Text] [Related]
6. Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study.
Timmermann L; Jain R; Chen L; Maarouf M; Barbe MT; Allert N; Brücke T; Kaiser I; Beirer S; Sejio F; Suarez E; Lozano B; Haegelen C; Vérin M; Porta M; Servello D; Gill S; Whone A; Van Dyck N; Alesch F
Lancet Neurol; 2015 Jul; 14(7):693-701. PubMed ID: 26027940
[TBL] [Abstract][Full Text] [Related]
7. Long-term effect of subthalamic nucleus deep brain stimulation on freezing of gait in Parkinson's disease.
Kim R; Kim HJ; Shin C; Park H; Kim A; Paek SH; Jeon B
J Neurosurg; 2019 Jan; 131(6):1797-1804. PubMed ID: 30641837
[TBL] [Abstract][Full Text] [Related]
8. Early versus Late Application of Subthalamic deep brain Stimulation to Parkinson's disease patients with motor complications (ELASS): protocol of a multicentre, prospective and observational study.
Jiang L; Poon WS; Moro E; Xian W; Yang C; Zhu XL; Gu J; Cai X; Liu J; Mok V; Liu Y; Xu S; Guo Q; Chen W; Chen L
BMJ Open; 2017 Nov; 7(11):e018610. PubMed ID: 29150478
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
[TBL] [Abstract][Full Text] [Related]
11. Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study.
Vitek JL; Jain R; Chen L; Tröster AI; Schrock LE; House PA; Giroux ML; Hebb AO; Farris SM; Whiting DM; Leichliter TA; Ostrem JL; San Luciano M; Galifianakis N; Verhagen Metman L; Sani S; Karl JA; Siddiqui MS; Tatter SB; Ul Haq I; Machado AG; Gostkowski M; Tagliati M; Mamelak AN; Okun MS; Foote KD; Moguel-Cobos G; Ponce FA; Pahwa R; Nazzaro JM; Buetefisch CM; Gross RE; Luca CC; Jagid JR; Revuelta GJ; Takacs I; Pourfar MH; Mogilner AY; Duker AP; Mandybur GT; Rosenow JM; Cooper SE; Park MC; Khandhar SM; Sedrak M; Phibbs FT; Pilitsis JG; Uitti RJ; Starr PA
Lancet Neurol; 2020 Jun; 19(6):491-501. PubMed ID: 32470421
[TBL] [Abstract][Full Text] [Related]
12. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
[TBL] [Abstract][Full Text] [Related]
13. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
[TBL] [Abstract][Full Text] [Related]
14. Quality of Life and Motor Outcomes in Patients With Parkinson's Disease 12 Months After Deep Brain Stimulation in China.
Zhang Y; Chen L; Sun B; Wang X; Wang J; Wang J; Woods J; Stromberg K; Shang H
Neuromodulation; 2023 Feb; 26(2):443-450. PubMed ID: 36411150
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
[TBL] [Abstract][Full Text] [Related]
16. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial.
Okun MS; Gallo BV; Mandybur G; Jagid J; Foote KD; Revilla FJ; Alterman R; Jankovic J; Simpson R; Junn F; Verhagen L; Arle JE; Ford B; Goodman RR; Stewart RM; Horn S; Baltuch GH; Kopell BH; Marshall F; Peichel D; Pahwa R; Lyons KE; Tröster AI; Vitek JL; Tagliati M;
Lancet Neurol; 2012 Feb; 11(2):140-9. PubMed ID: 22239915
[TBL] [Abstract][Full Text] [Related]
17. Imaging-based programming of subthalamic nucleus deep brain stimulation in Parkinson's disease.
Waldthaler J; Bopp M; Kühn N; Bacara B; Keuler M; Gjorgjevski M; Carl B; Timmermann L; Nimsky C; Pedrosa DJ
Brain Stimul; 2021; 14(5):1109-1117. PubMed ID: 34352356
[TBL] [Abstract][Full Text] [Related]
18. Directional DBS increases side-effect thresholds-A prospective, double-blind trial.
Dembek TA; Reker P; Visser-Vandewalle V; Wirths J; Treuer H; Klehr M; Roediger J; Dafsari HS; Barbe MT; Timmermann L
Mov Disord; 2017 Oct; 32(10):1380-1388. PubMed ID: 28843009
[TBL] [Abstract][Full Text] [Related]
19. Deep brain stimulation for Parkinson's disease: meta-analysis of results of randomized trials at varying lengths of follow-up.
Mansouri A; Taslimi S; Badhiwala JH; Witiw CD; Nassiri F; Odekerken VJJ; De Bie RMA; Kalia SK; Hodaie M; Munhoz RP; Fasano A; Lozano AM
J Neurosurg; 2018 Apr; 128(4):1199-1213. PubMed ID: 28665252
[TBL] [Abstract][Full Text] [Related]
20. Differential Effects of Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation on Motor Subtypes in Parkinson's Disease.
Fan S; Liu D; Shi L; Meng F; Fang H; Liu H; Zhang H; Yang A; Zhang J
World Neurosurg; 2022 Aug; 164():e245-e255. PubMed ID: 35489598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
